Summary
Interleukin-6 (IL-6) is a recently characterized pleiotropic cytokine with antitumor activity. We investigated the production of IL-6 by renal cell cancer (RCC) and the growth effects of IL-6 on RCC. Using immunoperoxidase staining, cytoplasmic IL-6 was detected in four of four renal tumor lines and in tumor cells from freshly nephrectomized RCC. We found that IL-6 mRNA was expressed at basal culture conditions by seven of ten RCC tumor lines tested. Biologically active IL-6, as measured by the B9 assay, was produced by all ten RCC tumor lines. The addition of tumor necrosis factor α (TNFα) significantly augmented the expression of IL-6 mRNA in five RCC tumor lines (P <0.05). The combination of interferon γ IFNγ and TNFα further enhanced the augmented IL-6 mRNA accumulation seen with TNFα alone (P <0.05). TNFα also significantly stimulated the production of biologically active IL-6 (P <0.01). Furthermore, IFNγ and TNFα were found to enhance IL-6 bioactivity synergistically (P <0.05). The growth effects of IL-6 on RCC were also investigated in two experimental systems: IL-6 was found to stimulate proliferative responses in six of six RCC tumor lines as measured by thymidine-uptake assays; however, only one of six tumor lines displayed an increase in proliferative response of greater than 21% (113%). The growth effect of IL-6 was further tested in clonogenic assays. One of the tumor lines tested displayed an enhanced growth response of up to 200%. We conclude that IL-6 is produced by RCC; this production is enhanced by TNFα with synergistic effects seen with IFNγ at both mRNA and protein levels. In turn, IL-6 may have a modest stimulatory growth effect on certain RCC tumor lines.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Aarden L, Lansdorp P, DeGroot E (1985) A growth factor for B cell hybridomas produced by human monocytes. Lymphokines 10: 175
Aarden LA, DeGroot ER, Schaap OL, Lansdorf P (1987) Production of hybridoma growth factor by human monocytes. Eur J Immunol 17: 1411
Akashi M, Loussararian AH, Adelman DC, Saito M, Koeffler HP (1990) Role of lymphotoxin in expression of interleukin 6 in human fibroblasts. J Clin Invest 85: 121
Betsholtz C, Westermark B, Ek B, Heldin CH (1984) Co-expression of a PDGF like growth factor and PDGF receptors in a human osteosarcoma cell line: implications for autocrine receptor activity. Cell 39: 447
Brach BA, Cicco NA, Riedel D, Hirano T, Kishimoto T, Mertelsmann RH, Herrmann F (1990) Mechanisms of differential regulation of interleukin-6 mRNA accumulation by tumor necrosis factor α and lymphotoxin during monocytic differentiation. FEBS Lett 263: 349
Brouckaert PGG, Leroux-Roels GG, Guisez Y, Tavernier J, Fiers W (1986) In vivo anti-tumour activity of recombinant human and murine TNF, alone and in combination with murine IFNγ, on a syngeneic murine melanoma. Int J Cancer 38: 763
Brouckaert P, Spriggs D, Demetri G, Kufe DW, Fiers W (1989) Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon γ. J Exp Med 169: 2257
Chen L, Mory Y, Zilberstein A, Revel M (1988) Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-B2. Proc Natl Acad Sci USA 85: 8037
Content J, De Wit L, Poupart P, Opdenakker G, Van Damme J, Billiau A (1985) Induction of a 26-kDa-protein mRNA in human cells treated with an interleukin-1-related, leukocyte-derived factor. Eur J Biochem 152: 253
Damme JV, Opdenakker G, Simpson RJ, Rubira MR, Cayphas S, Vink A, Billau A, Snick JV (1987) Identification of the human 26-kD protein, interferon B2(IFN-B2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor. J Exp Med 165: 914
Defilippi P, Poupart P, Tavernier J, Fiers W, Content J (1987) Induction and regulation of mRNA encoding 26-kDa protein in human cell lines treated with recombinant human tumor necrosis factor. Proc Natl Acad Sci USA 84: 4557
Demetri GD, Spriggs DR, Sherman ML, Arthur K, Imamura K, Frei III E, Kufe DW (1988) Recombinant human tumor necrosis factor and gamma interferon: phase I study of therapy with overlapping 24 hour infusions. Proc Am Soc Clin Oncol Annu Meet 7: 173
Dinarello CA, Cannon JG, Wolff SM, Bernheim HA, Beutler B, Cerami A, Figarl IS, Falladino MA, O'Connor JB (1986) Tumor necrosis factor(cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 163: 1433
Gauldie J, Richards C, Harnish D, Lansdorp P, Baumann H (1987) Interferon b2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 84: 7251
Gomella LG, Sargent ER, Wade TR, Anglard P, Linehan WM, Kasid A (1989) Expression of transforming growth factor α in normal human adult kidney and enhanced expression of transforming growth factors α and β1 in renal cell carcinoma. Cancer Res 49: 6972
Hamburger AW, Salmon SE (1977) Primary bioassay of human tumor stem cells. Science 197: 461
Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, Kashiwamura S, Nakajima K, Koyama K, Iwamatu A, Tsunasawa S, Sakiyama F, Matsui H, Takahara Y, Taniguchi Y, Kishimoto T (1986) Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324: 73
Horii Y, Maraguchi A, Suematsu S, Matsuda T, Yoshizaki K, Hirano T, Kishimoto T (1988) Regulation of BSF-2/IL-6 production by human mononuclear cells. J Immunol 141: 1529
Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H, Kuramoto A, Kishimoto T (1988) Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332: 83
Kishimoto T (1987) B cell stimulatory factors(BSFs). Molecular structure, biological function, and regulation of expression. J Clin Immunol 7: 343
Kohase M, Henriksen-DeStefano D, May LT, Vilcek J, Sehgal PB (1986) Induction of B2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation. Cell 45: 659
Kohase M, May LT, Tamm I, Vilcek J, Sehgal PB (1987) A cytokine network in human diploid fibroblasts: interaction of B-interferons, tumor necrosis factor, platelet-derived growth factor, and interleukin-1. Mol Cell Biol 7: 273
Leary AG, Ikebuchi K, Hirai Y, Wong GG, Yang YC, Clark SC, Ogawa M (1988) Synergism between interleukin-6 and interleukin-3 in supporting proliferation of human hematopoetic stem cells; comparison with interleukin-1α. Blood 71: 1759
Lewis GD, Aggarwal BB, Eessalu TE, Sugarman BJ, Shepard HM (1987) Modulation of the growth of transformed cells by human tumor necrosis factor-α and interferon-γ. Cancer Res 47: 5382
Lowik CWGM, van der Pluijm G, Bloys H, Hoekman K, Bijvoet OLM, Aarden LA, Papapoulos SE (1989) Parathyroid hormone (PTH) and PTH-like protein (PLP) production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis. Biochem Biophys Res Commun 162: 1546
May LT, Helfgott DC, Sehgal PB (1986) Anti-B-interferon antibodies inhibit the increased expression of HLA-B7 mRNA in tumor necrosis factor-treated human fibroblasts: structural studies of the B2 interferon involved. Proc Natl Acad Sci USA 83: 8957
Miki S, Iwano M, Miki Y, Yamamato M, Tang B, Yokokawa K, Sonoda T, Dirano T, Kishimoto T (1989) Interleukin 6(IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett 250: 607
Miles SA, Rezai AR, Salazar-Gonzalez JF, Meyden MV, Stevens RH, Logan DM, Mitsuyasu RT, Taga T, Hirano T, Kishimoto T, Martinez-Maza O (1990) AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc Natl Acad Sci USA 87: 4068
Miyaura C, Onozaki K, Akiyama Y, Taniyama T, Hirano T, Kishimoto T, Suda T (1988) Recombinant human interleukin 6(B-cell stimulatory factor 2) is a potent inducer of differentiation of mouse myeloid leukemia cells (M1). FEBS Lett 234: 17
Mule JJ, McIntosh JK, Jablons DM, Rosenberg SA (1990) Antitumor activity of recombinant interleukin 6 in mice. J Exp Med 171: 629
Nijstein MWN, DeGroot ER, Ten Duis JH, Hack CE, Aarden LA (1987) Serum levels of interleukin-6 and acute phase responses. Lancet 2: 921
Ramakrishran S, Xu FJ, Brant SJ, Niedel JE, Bast RD Jr, Brown EL (1989) Constitutive production of macrophage colony-stimulating factor by human ovarian and breast carcinoma cell lines. J Clin Invest 83: 921
Schwab G, Siegall C, Aarden L, Neckers L, Nordan R (1990) Identification of an IL-6-modulated autocrine growth loop in a human multiple myeloma cell line. Proc Am Assoc Cancer Res 31: 243
Tosato G, Gerrard TL, Goldman NG, Pike SE (1988) Stimulation of EBV-activated human B cells by monocytes and monocyte products. J Immunol 140: 4329
Tosato G, Tanner J, Jones KD, Revel M, Pike SE (1990) Identification of Interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells. J Virol 64: 3033
Tweeddale M, Jamal N, Nguyen A, Wang XH, Minden MD, Messner HA (1989) Production of growth factors by malignant lymphoma cell lines. Blood 74: 572
Van Damme J, Van Beeumen H, Decock B, Van Snick J, De Ley M, Billiqu A (1988) Separation and comparison of two monokines with lymphocyte-activating factor activity: IL-1B and hybridoma growth factor(HGF). J Immunol 140: 1534
Watson JM, Sensintaffar J, Berek J, Martinez-Maza O (1990) Constitutive production of IL-6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res 50: 6959
Yee C, Biondi A, Wang XH, Iscove NN, de Sousa J, Aarden LA, Wong GG, Clar SC, Messner HA, Minden MD (1989) A possible autocrine role for interleukin-6 in two lymphoma cell lines. Blood 74: 798
Zilberstein A, Ruggieri R, Korn JH, Chen L, Mory Y, Shulman L, Revel M (1987) Biological activities of human interferon B-2 produced by cDNA expression in hamster cells and possible autocrine functions of this cytokine-induced IFN. In: Cantell K, Schellekens H (eds) The biology of the interferon System. Nijhoff, Boston, p 165
Zilberstein A, Ruggieri R, Korn JH, Revel M (1989) Structure and expression of cDNA and genes for human interferon-β-2, a distinct species inducible by growth-stimulatory cytokines. EMBO J 5: 2529
Author information
Authors and Affiliations
Additional information
This work was supported in part by National Institutes of Health Grant CA 522 499-01, and the Margaret Early Foundation
Rights and permissions
About this article
Cite this article
Koo, A.S., Armstrong, C., Bochner, B. et al. Interleukin-6 and renal cell cancer: Production, regulation, and growth effects. Cancer Immunol Immunother 35, 97–105 (1992). https://doi.org/10.1007/BF01741856
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01741856